Control 2 In ‘Concept Stage’ As Remedy Announces Development Deal With 505 Games

Control 2

Remedy Entertainment has actually revealed a brand-new bargain with author 505 Games to co-develop as well as market Control 2. The information likewise gave understanding right into the follow up’s advancement standing. 

According to a press release, Control 2 (when referred to as Codename Heron) is presently in the idea stage, being constructed in Remedy’s proprietary Northlight engine. The game will certainly be readily available on PlayStation 5, Xbox Series X/S, as well as computer. Remedy will certainly release the computer variation while 505 will certainly deal with the game’s console launches. Control 2 has no launch home window, yet Remedy did launch an item of idea art, uploaded listed below. 

The news release likewise mentions that Control 2’s advancement spending plan originally rested at 50 million euros. Remedy as well as 505 will just as divide advertising as well as advancement prices, along with earnings produced by its launch. Remedy keeps complete possession of the Control IP, nonetheless. The presss launch likewise discloses that the initial Control has actually offered over 3 million duplicates given that releasing in 2019. 

“We are excited to deepen our cooperation with Remedy and continue the success story of Control together,” state Rami as well as Raffi Galante, co-CEOs of Digital Bros Group/505 Games. “… Control is the biggest investment 505 Games has ever made, so it has a special place in our hearts. We are grateful to the whole player community that has made Control such a long-lasting and loved game, and are even more excited to bring out Control 2.”

This statement was initial teased last June, when Remedy as well as 505 exposed prepare for brand-new triple-A Control experiences. That exact same upgrade exposed a forthcoming multiplayer spin-off title referred to as Project Condor. Earlier this year, Remedy likewise struck a take care of Rockstar to establish remakes of Max Payne 1 and 2


Read also